Literature DB >> 23574430

Multifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxel.

Mahmoud Elsabahy1, Ritu Shrestha, Corrie Clark, Sara Taylor, Jeffrey Leonard, Karen L Wooley.   

Abstract

Development of multifunctional nanostructures that can be tuned to codeliver multiple drugs and diagnostic agents to diseased tissues is of great importance. Hierarchically assembled theranostic (HAT) nanostructures based on anionic cylindrical shell cross-linked nanoparticles and cationic shell cross-linked knedel-like nanoparticles (cSCKs) have recently been developed by our group to deliver siRNA intracellularly and to undergo radiolabeling. In the current study, paclitaxel, a hydrophobic anticancer drug, and siRNA have been successfully loaded into the cylindrical and spherical components of the hierarchical assemblies, respectively. Cytotoxicity, immunotoxicity, and intracellular delivery mechanism of the HAT nanostructures and their individual components have been investigated. Decoration of nanoparticles with F3-tumor homing peptide was shown to enhance the selective cellular uptake of the spherical particles, whereas the HAT nanoassemblies underwent an interesting disassembly process in contact with either OVCAR-3 or RAW 264.7 cell lines. The HAT nanostructures were found to "stick" to the cell membrane and "trigger" the release of spherical cSCKs templated onto their surfaces intracellularly, while retaining the cylindrical part on the cell surface. Combination of paclitaxel and cell-death siRNA (siRNA that induces cell death) into the HAT nanostructures resulted in greater reduction in cell viability than siRNA complexed with Lipofectamine and the assemblies loaded with the individual drugs. In addition, a shape-dependent immunotoxicity was observed for both spherical and cylindrical nanoparticles with the latter being highly immunotoxic. Supramolecular assembly of the two nanoparticles into the HAT nanostructures significantly reduced the immunotoxicity of both cSCKs and cylinders. HAT nanostructures decorated with targeting moieties, loaded with nucleic acids, hydrophobic drugs, radiolabels, and fluorophores, with control over their toxicity, immunotoxicity, and intracellular delivery might have great potential for biomedical delivery applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574430      PMCID: PMC3681414          DOI: 10.1021/nl4006645

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  48 in total

1.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

2.  Shape effects of filaments versus spherical particles in flow and drug delivery.

Authors:  Yan Geng; Paul Dalhaimer; Shenshen Cai; Richard Tsai; Manorama Tewari; Tamara Minko; Dennis E Discher
Journal:  Nat Nanotechnol       Date:  2007-03-25       Impact factor: 39.213

3.  Benzaldehyde-functionalized polymer vesicles.

Authors:  Guorong Sun; Huafeng Fang; Chong Cheng; Peng Lu; Ke Zhang; Amy V Walker; John-Stephen A Taylor; Karen L Wooley
Journal:  ACS Nano       Date:  2009-03-24       Impact factor: 15.881

4.  Multicompartment polymer nanostructures with ratiometric dual-emission pH-sensitivity.

Authors:  Guorong Sun; Honggang Cui; Lily Yun Lin; Nam S Lee; Chao Yang; William L Neumann; John N Freskos; Jeng J Shieh; Richard B Dorshow; Karen L Wooley
Journal:  J Am Chem Soc       Date:  2011-05-16       Impact factor: 15.419

5.  Dynamic cylindrical assembly of triblock copolymers by a hierarchical process of covalent and supramolecular interactions.

Authors:  Zhou Li; Jun Ma; Nam S Lee; Karen L Wooley
Journal:  J Am Chem Soc       Date:  2011-01-04       Impact factor: 15.419

6.  Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin.

Authors:  Lily Yun Lin; Nam S Lee; Jiahua Zhu; Andreas M Nyström; Darrin J Pochan; Richard B Dorshow; Karen L Wooley
Journal:  J Control Release       Date:  2011-01-15       Impact factor: 9.776

7.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

Authors:  Alex M Chen; Min Zhang; Dongguang Wei; Dirk Stueber; Oleh Taratula; Tamara Minko; Huixin He
Journal:  Small       Date:  2009-12       Impact factor: 13.281

8.  In vitro characterization of a targeted, dye-loaded nanodevice for intraoperative tumor delineation.

Authors:  Daniel A Orringer; Yong-Eun L Koo; Thomas Chen; Gwangseong Kim; Hoe Jin Hah; Hao Xu; Shouyan Wang; Richard Keep; Martin A Philbert; Raoul Kopelman; Oren Sagher
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654

9.  Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.

Authors:  Yunching Chen; Jinzi J Wu; Leaf Huang
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

10.  Isoforms of caveolin-1 and caveolar structure.

Authors:  T Fujimoto; H Kogo; R Nomura; T Une
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  11 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

2.  Differential immunotoxicities of poly(ethylene glycol)- vs. poly(carboxybetaine)-coated nanoparticles.

Authors:  Mahmoud Elsabahy; Ang Li; Fuwu Zhang; Deborah Sultan; Yongjian Liu; Karen L Wooley
Journal:  J Control Release       Date:  2013-09-20       Impact factor: 9.776

3.  Data Mining as a Guide for the Construction of Cross-Linked Nanoparticles with Low Immunotoxicity via Control of Polymer Chemistry and Supramolecular Assembly.

Authors:  Mahmoud Elsabahy; Karen L Wooley
Journal:  Acc Chem Res       Date:  2015-05-26       Impact factor: 22.384

4.  Shell-crosslinked knedel-like nanoparticles induce lower immunotoxicity than their non-crosslinked analogs.

Authors:  Mahmoud Elsabahy; Sandani Samarajeewa; Jeffery E Raymond; Corrie Clark; Karen L Wooley
Journal:  J Mater Chem B       Date:  2013-10-21       Impact factor: 6.331

5.  Niosomes: A Strategy toward Prevention of Clinically Significant Drug Incompatibilities.

Authors:  Hebatallah B Mohamed; Sohair M El-Shanawany; Mostafa A Hamad; Mahmoud Elsabahy
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

6.  Morphology-Variable Aggregates Prepared from Cholesterol-Containing Amphiphilic Glycopolymers: Their Protein Recognition/Adsorption and Drug Delivery Applications.

Authors:  Zhao Wang; Ting Luo; Amin Cao; Jingjing Sun; Lin Jia; Ruilong Sheng
Journal:  Nanomaterials (Basel)       Date:  2018-02-28       Impact factor: 5.076

7.  Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.

Authors:  Hadeel Elzeny; Fuwu Zhang; Esraa N Ali; Heba A Fathi; Shiyi Zhang; Richen Li; Mohamed A El-Mokhtar; Mostafa A Hamad; Karen L Wooley; Mahmoud Elsabahy
Journal:  Drug Des Devel Ther       Date:  2017-02-22       Impact factor: 4.162

8.  Development of Fully Degradable Phosphonium-Functionalized Amphiphilic Diblock Copolymers for Nucleic Acids Delivery.

Authors:  Yannick P Borguet; Sarosh Khan; Amandine Noel; Sean P Gunsten; Steven L Brody; Mahmoud Elsabahy; Karen L Wooley
Journal:  Biomacromolecules       Date:  2018-03-11       Impact factor: 6.988

9.  Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles.

Authors:  Mahmoud Elsabahy; Shiyi Zhang; Fuwu Zhang; Zhou J Deng; Young H Lim; Hai Wang; Perouza Parsamian; Paula T Hammond; Karen L Wooley
Journal:  Sci Rep       Date:  2013-11-22       Impact factor: 4.379

Review 10.  Targeted Delivery of siRNA Therapeutics to Malignant Tumors.

Authors:  Qixin Leng; Martin C Woodle; A James Mixson
Journal:  J Drug Deliv       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.